Our current health care reimbursement system rewards procedures and undervalues the time spent talking with patients and learning their history, which speaks to the need for primary care redesign, according to Vineet Arora, MD, MAPP, dean for medical education at UChicago Medicine.
Our current health care reimbursement system rewards procedures and undervalues the time spent talking with patients and learning their history, which speaks to the need for primary care redesign, according to Vineet Arora, MD, MAPP, dean for medical education at UChicago Medicine. This interview was conducted ahead of the 2022 Patient-Centered Oncology Care® meeting, at which Ishani Ganguli, MD, MPH, received the Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Transcript
Is it possible to reconcile the tension between what’s rewarded in the health care payment system and the principles that physicians actually value?
Oh, wow, that's a tough question. But yes, I did say that—a lot of people talk about how we've got to measure what matters, right. I mean, that's sort of very germane to your group of attendees at this conference. I think that we also have to pay for what matters in clinical care. And, unfortunately, the [relative value unit]–based system that we have for clinical care, especially for payment of clinicians, rewards procedures and overmedicalization, right, and it undervalues talking to patients.
I was just on service, and I’m struck by how, even we say this in medical school, so much of it is getting a good history. We don’t pay people to get good histories, and as a result, we have short visits, we don’t get good information. If we just had time to really have those productive, trusted relationships with our patients, we might be able to get the right information that would lead to the right test ordering, as opposed to the shotgun approach that sometimes occurs because you’re like, “I have to move on to the next patient and time is ticking.”
I think this visit-based approach, where it rewards procedures at the expense of undervaluing the visit of actually taking a good history, is challenging. I do know procedures are very complex, and they deserve payment, but I do think there’s got to be something to be said for good primary care. And we know that countries that have good primary care and reward primary care have not just better outcomes, they have lower costs, and those are both things that we need in the United States. So, I would say we need to think about strategic investments in primary care and primary care redesign, which of course I know that many people are working on here as well as Dr Ganguli.
Infant Mortality Increases Across US Following Dobbs Decision
October 25th 2024The Dobbs decision was associated with a 7% absolute increase in overall infant mortality—equivalent to 247 excess deaths—and a 10% increase among infants with congenital anomalies, corresponding to 204 additional deaths.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More